GLP-1s Don’t Appear to Worsen Diabetic Retinopathy

by Medscape • 2023/11/14 • 0 Comments

Most patients with diabetic retinopathy who take the GLP-1 agonist semaglutide don't experience a worsening of the condition, a new study found, but they still require screening and follow-up.
Medscape Medical News

Full Story →

← Alcon Reports Third Quarter 2023 Results

Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs →

Post navigation